Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
36,733,208
-
Share change
-
-1,061,964
-
Total reported value
-
$1,875,786,404
-
Put/Call ratio
-
124%
-
Price per share
-
$51.06
-
Number of holders
-
161
-
Value change
-
-$50,072,012
-
Number of buys
-
89
-
Number of sells
-
62
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2016
As of 31 Dec 2016,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,733,208 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, OppenheimerFunds, Inc., BlackRock Fund Advisors, STATE STREET CORP, FRANKLIN RESOURCES INC, BB BIOTECH AG, OAK RIDGE INVESTMENTS LLC, and Palo Alto Investors, LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.